A Multicenter, Randomized, Single Blind, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety After Administration of CKD-845 in Males
Latest Information Update: 30 Sep 2022
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 26 Sep 2022 Status changed from recruiting to completed.
- 24 Dec 2020 New trial record